Baker Brothers Advisors - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$254,183,000
+113.1%
3,732,5020.0%1.66%
+145.9%
Q2 2022$119,253,000
+3.9%
3,732,502
+12.6%
0.68%
+2.6%
Q1 2022$114,823,000
+18.3%
3,314,7650.0%0.66%
+39.8%
Q4 2021$97,023,000
+18.3%
3,314,765
+3.0%
0.47%
+31.1%
Q3 2021$81,980,000
-27.2%
3,217,4410.0%0.36%
-27.3%
Q2 2021$112,675,000
-14.1%
3,217,4410.0%0.50%
-12.9%
Q1 2021$131,111,000
+228.9%
3,217,441
+249.6%
0.57%
+278.7%
Q4 2020$39,861,000
-21.5%
920,3750.0%0.15%
-26.1%
Q3 2020$50,749,000
+1610.4%
920,375
+1858.2%
0.20%
+1461.5%
Q2 2020$2,967,000
+23.6%
47,0000.0%0.01%
-13.3%
Q1 2020$2,401,000
-74.8%
47,000
-92.2%
0.02%
-85.0%
Q1 2016$9,516,000
-26.4%
600,000
+50.0%
0.10%
-6.5%
Q4 2015$12,932,000
+53.4%
400,000
+100.0%
0.11%
+37.2%
Q3 2015$8,432,000200,0000.08%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders